| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |